Q-Sights Key Insights – Week 16

7/6/20220 -7/10/2020

Here are the key topics you need to know about COVID-19 this week. To help you stay abreast of the latest COVID-19 news, guidelines and best practices from Federal, State, National Health Agencies and QHR Health, visit the QHR Health COVID-19 Online Resource Center.

Supply Chain and Pharmacy

  • QHR Health Supply Chain COVID-19 Warehouse program is pleased to communicate 100% order fulfillment for 31 facilities.

  • Reminder that the warehouse ordering cycle has moved to bi-weekly. Please anticipate bi-weekly needs when placing orders.
    • The next requisition sheet will be sent out Thursday, July 16th (due back Friday, July 17th)
    • The following requisition sheet will be sent out on Thursday, August 6th, (due back Friday, August 7th), which will initiate a bi-weekly ordering cycle

  • The warehouse has limited quantities of the following items:
    • Tyvek Suits XL and XXL
    • XL Gloves in box counts of 90, 180, & 250
    • M Gloves box of 300
    • Disposable Ponchos
    • Dupont shoe covers M & XL

  • Remdesivir from Gilead will be available to purchase in allocated amounts determined by HHS and state health departments. It will not be commercially available and is approved only by the EUA for treatment of COVID-19.
    • Amerisource is distributing the product at the direction of the Department of Health and Human Services (HHS) and state departments of health
      • HHS will designate the amount of product to each state and state health departments will allocate product to specific sites, based upon COVID-19 burden.
      • AmerisourceBergen nor Gilead allocate any product.
    • If you have an existing ASD account prior to COVID, that account should be okay to use. You can proactively reach out to sales@asdhealthcare.com to verify and if a new account is needed they will assist you. If you do not have an account with ASD you can reach out to sales@asdhealth.com to get it started.
    • Amerisource expects to have allocations by July 10 and begin contacting eligible sites the week of July 13.
    • Hospitals that receive Remdesivir will pay no more than Gilead’s Wholesale Acquisition Cost (WAC) and will not receive additional discounts. Current cost is $520 per vial.
    • Any site with questions can call the Remdesivir hotline at 877-987-4987 or email remdesivir@amerisourcebergen.com.
    • Fact Sheet on Remdesivir for the Commercial Marketplace

  • For the latest Pharmacy information, continue to monitor HealthTrust’s COVID-19 Pharmacy Resource Center.

Clinical Care

  • Coping with stress is now more important than ever as we continue to face the challenges at work, at home, in our communities related to COVID-19.
    • QHR Health’s Cathy Stern, Manager, Clinical and Operational Improvement, has written an article about the importance of taking care of each other and working together. 
    • The CDC has released resources to help cope with stress and check-in on mental health during COVID-19.

  • news release from the EPA approves surface disinfectant products effective against SARS-COV-2 (COVID-19).

Visit the QHR Health COVID-19 Online Resource Center site as often as you’d like as we are providing live news feeds from the CDC and CMS to keep all of us updated on the latest news. There is also a document library link located in the bottom right-hand corner of the page where information is being organized by subject categories.

If you need assistance, please reach out to your QHR Health representative.